Burzynski Research Institute (BZYR) Other Operating Expenses (2010 - 2018)
Burzynski Research Institute (BZYR) posted Other Operating Expenses of $600.0 for Q1 2018, up 250.88% sequentially from $171.0 in Q1 2017, and up 250.88% YoY from $171.0 in Q1 2017.
Burzynski Research Institute (BZYR) Other Operating Expenses (2010 - 2018) Analysis & Trends
Burzynski Research Institute has reported Other Operating Expenses for 9 years, with the latest figure at $600.0 in Q1 2018.
- Quarterly Other Operating Expenses rose 250.88% year-over-year to $600.0 in Q1 2018, while the trailing twelve-month figure through Nov 2018 was $600.0 (up 250.88% YoY) and the FY2018 annual result came in at $600.0, down 12.28% from the prior year.
- Other Operating Expenses improved to $600.0 in Q1 2018 per BZYR's latest filing, from $171.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $600.0 in Q1 2018 and troughed at $171.0 in Q1 2014.
- A 5-year average of $201.64 and a median of $171.0 in 2014 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2014 and 2018: Other Operating Expenses changed 0.0% in 2014, then surged 250.88% in 2018.
- Over 5 years, Other Operating Expenses stood at $171.0 in 2014, then changed by 0.0% to $171.0 in 2015, then changed by 0.0% to $171.0 in 2016, then changed by 0.0% to $171.0 in 2017, then soared by 250.88% to $600.0 in 2018.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $600.0, $171.0, and $171.0 for Q1 2018, Q1 2017, and Q4 2016 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Burzynski Research Institute | 1.31 Mn | 1.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2018 | 600.00 |
| Feb 28, 2017 | 171.00 |
| Nov 30, 2016 | 171.00 |
| Aug 31, 2016 | 171.00 |
| May 31, 2016 | 171.00 |
| Feb 29, 2016 | 171.00 |
| Nov 30, 2015 | 171.00 |
| Aug 31, 2015 | 171.00 |
| May 31, 2015 | 171.00 |
| Feb 28, 2015 | 171.00 |
| Nov 30, 2014 | 171.00 |
| Aug 31, 2014 | 171.00 |
| May 31, 2014 | 171.00 |
| Feb 28, 2014 | 171.00 |
| Nov 30, 2013 | 171.00 |
| Aug 31, 2013 | 171.00 |
| May 31, 2013 | 171.00 |
| Feb 28, 2013 | 170.00 |
| Nov 30, 2012 | 171.00 |
| Aug 31, 2012 | 171.00 |